Webinar: Anaesthesia and Cancer Care
Join us for a webinar, held in association with the Royal Society of Medicine (RSM), where leading experts from around the world will discuss anaesthesia and cancer care.
Anaesthesia is performed daily across the globe and has a direct influence on cancer outcomes. This webinar aims to bring together anaesthesia and oncology clinicians to share their expertise, improve patient care and reduce the global burden of cancer.
During the webinar, Professor Wayne Morriss, President of the WFSA, will chair and question a panel of three world-renowned experts in the field of onco-anaesthesiology from the USA, India and Australia.
Attendees will be able to:
- Create better outcomes for cancer patients by improving their knowledge of anaesthesia and perioperative patient care
- Understand how anaesthesia and cancer care can be improved through collaboration
- Explore how to reduce the global burden of cancer
Teaching, training, and clinical research in the area of Cancer Pain and Palliative Care for two decades. At the national level, leading pivotal role in finalizing government of India policies and protocol of Pain/Palliative Care and opioid availability throughout India. At the international level, assisting organizations like IAHPC/APHN in advocacy and training in South East Asian Countries in areas of Pain and Palliative Care. Organized 19 major International Pain and Palliative Care Conferences in various parts of India since 2009 on a yearly basis. On the Board of Directors of International Association of Hospice and Palliative Care (IAHPC), Chief Editor, Indian Journal of Palliative Care (since 2009), Editorial Board Member of World Journal of Anaesthesiology and Annals of Palliative Medicine and recipient of ‘Award of Excellence in Palliative Medicine amongst SAARC countries’ and ‘Susan Raj Pain Physician of the year 2012-2013’ Awards.
Professor Gottumukkala has over 30 years of experience in Anesthesiology & Perioperative Medicine. He is currently a Professor and Deputy Chairman of Anesthesiology & Perioperative Medicine at the University of Texas MD Anderson Cancer Center. He also serves as the Medical Director for the Program for Advancement of Perioperative Cancer Care (PACE), and as an Associate Head for the Institute for Cancer Care Innovation (ICCI). Prof Gottumukkala’s main research and academic interests are Perioperative management strategies to improve postoperative and oncological outcomes, Enhanced Recovery Protocols in major cancer surgery, and developing Onco-Anesthesiology as a specialty.
Bernhard is the Director of the Department of Anesthesia, Perioperative and Pain Medicine at the Peter MacCallum Cancer Centre, with an honorary academic appointment at the University of Melbourne.
Previous academic and clinical appointments included: Professor and Deputy Chair in Anesthesiology and Intensive Care Medicine at The University of Texas M.D. Anderson Cancer Centre; Professor in Cardiac Anaesthesia at Vanderbilt University (USA); and Consultant Anaesthetist, Royal Brompton & Harefield NHS Trust, London. UK.
Bernhard’s academic interests focus on improving surgical outcomes, especially following cancer surgery—with strategies for enhanced risk stratification (including measuring functional capacity with cardiopulmonary exercise testing, assessing underlying endothelial dysfunction) and preoperative optimization (including prehabilitation with exercise therapy and haematinic optimization) to reduce complications after surgery. Specific to the field of onco-anaesthesia, Bernhard’s research collaborative investigates the interaction of perioperative adrenergic-inflammatory response and anaesthetic technique on tumor-progression signaling on the potential long-term postoperative complication—cancer recurrence. Bernhard’s collaborative research program to date has resulted in more than 30 research grants, more than 100 peer-reviewed / invited articles, 3 edited books (including ‘Acute Care of the Cancer Patient’), and 13 awards presented to him and his team for education, research and clinical quality improvement initiatives.